Kurtz Ronald M MD

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return 33% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Kurtz Ronald M MD's trades of Rxsight Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Rxsight Inc (RXST)
Transaction date
Proposed sale
Price
293.58
Quantity 21,676
Value US$2,484,089
US Rxsight Inc (RXST)
Transaction date
Sale
Price
473.61
Quantity 62,285 +39.7%
Value US$1,506,462
US Rxsight Inc (RXST)
Transaction date
Planned sale
Price
174.11
Quantity 3,895 +34.8%
Value US$2,496,003
US Rxsight Inc (RXST)
Transaction date
Proposed sale
Price
60.05
Quantity 40,000
Value US$2,401,845
US Rxsight Inc (RXST)
Transaction date
Planned sale
Price
45.00
Quantity 31,250 -3.7%
Value US$1,406,256
US Rxsight Inc (RXST)
Transaction date
Planned sale
Price
43.50
Quantity 31,250 -3.6%
Value US$1,359,375
US Rxsight Inc (RXST)
Transaction date
Proposed sale
Price
44.15
Quantity 62,500
Value US$2,759,352
US Rxsight Inc (RXST)
Transaction date
Planned sale
Price
41.09
Quantity 22,500 -2.5%
Value US$924,498
US Rxsight Inc (RXST)
Transaction date
Proposed sale
Price
40.99
Quantity 22,500
Value US$922,234
US Rxsight Inc (RXST)
Transaction date
Planned sale
Price
39.40
Quantity 20,000 -2.2%
Value US$788,022
US Rxsight Inc (RXST)
Transaction date
Planned sale
Price
40.01
Quantity 20,000 -2.2%
Value US$800,164
US Rxsight Inc (RXST)
Transaction date
Proposed sale
Price
39.60
Quantity 40,000
Value US$1,584,167
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-02 2026-09-02
US Rxsight Inc (RXST)
PrS Proposed sale
21,676
293.58
US$2,484,089 		21,676 293.58 US$2,484,089
2026-09-02 2026-09-02
US Rxsight Inc (RXST)
S Sale
62,285 +39.7%
473.61
US$1,506,462 		62,285 +39.7% 473.61 US$1,506,462
2024-05-06 2024-05-03
US Rxsight Inc (RXST)
PlS Planned sale
3,895 +34.8%
174.11
US$2,496,003 		3,895 +34.8% 174.11 US$2,496,003
2024-05-03 2024-05-03
US Rxsight Inc (RXST)
PrS Proposed sale
40,000
60.05
US$2,401,845 		40,000 60.05 US$2,401,845
2024-01-09 2024-01-08
US Rxsight Inc (RXST)
PlS Planned sale
31,250 -3.7%
45.00
US$1,406,256 		31,250 -3.7% 45.00 US$1,406,256
2024-01-09 2024-01-08
US Rxsight Inc (RXST)
PlS Planned sale
31,250 -3.6%
43.50
US$1,359,375 		31,250 -3.6% 43.50 US$1,359,375
2024-01-08 2024-01-08
US Rxsight Inc (RXST)
PrS Proposed sale
62,500
44.15
US$2,759,352 		62,500 44.15 US$2,759,352
2023-12-29 2023-12-27
US Rxsight Inc (RXST)
PlS Planned sale
22,500 -2.5%
41.09
US$924,498 		22,500 -2.5% 41.09 US$924,498
2023-12-27 2023-12-27
US Rxsight Inc (RXST)
PrS Proposed sale
22,500
40.99
US$922,234 		22,500 40.99 US$922,234
2023-12-18 2023-12-14
US Rxsight Inc (RXST)
PlS Planned sale
20,000 -2.2%
39.40
US$788,022 		20,000 -2.2% 39.40 US$788,022
2023-12-18 2023-12-14
US Rxsight Inc (RXST)
PlS Planned sale
20,000 -2.2%
40.01
US$800,164 		20,000 -2.2% 40.01 US$800,164
2023-12-14 2023-12-14
US Rxsight Inc (RXST)
PrS Proposed sale
40,000
39.60
US$1,584,167 		40,000 39.60 US$1,584,167